AML1-ETO oncogenic fusion protein; dihydrofolate reductase (DHFR) BriefCommunication Pages: 736 - 736
BRCA1-associated RING domain 1 (BARD1); SNP rs6435862; SNP rs3768716 BriefCommunication Pages: 738 - 738
GATA binding protein 3 (GATA3); cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (CDKN2C; p18INK4c) BriefCommunication Pages: 739 - 739
N-cadherin; snail1; twist homolog (TWIST); vimentin (VIM); Y box-binding protein I (YB1) BriefCommunication Pages: 740 - 740
HER2 (ERBB2; neu); peroxiredoxin 1 (PRDX1); phosphatase and tensin homolog deleted on chromosome ten (PTEN; MMAC1; TEP1) BriefCommunication Pages: 742 - 742
Influenza A virus hemagglutinin (HA); Influenza A virus neuraminidase (NA); Influenza A virus matrix protein M2 (M2); Influenza A virus PB1-F2 protein (PB1-F2) BriefCommunication Pages: 753 - 753
Mycobacterium tuberculosis transcriptional regulatory repressor protein EthR (EthR; Rv3855) BriefCommunication Pages: 754 - 754
Astrotactin 2 (ASTN2); constitutive photomorphogenic 1 (RFWD2; COP1); contactin 4 (CNTN4); F-box protein 40 (FBXO40); neuroligin 1 (NLGN1); neurexin 1 (NRXN1); parkin (PARK2); ubiquitin protein ligase E3A (UBE3A; E6AP); cadherin 9 type 2 T1 (CDH9); cadherin 10 type 2 T2 (CDH10) BriefCommunication Pages: 756 - 756
Apoptosis regulator through modulating IAP expression (ARIA); baculoviral IAP repeat-containing 2 (BIRC2; cIAP1); BIRC3 (cIAP2) BriefCommunication Pages: 763 - 763
Genetic test to predict malignant pleural mesothelioma response to surgery BriefCommunication Pages: 765 - 765
Rationalization and prediction of adverse drug reactions on the basis of chemical structure BriefCommunication Pages: 766 - 766
LIM homeobox transcription factor 1α (LMX1A) expression for efficient production of mesencephalic dopamine (mesDA) neurons BriefCommunication Pages: 770 - 770
Pluripotency reporter system to increase selection efficiency for human induced pluripotent stem (iPS) cells BriefCommunication Pages: 771 - 771